Poniard To Presents Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial

Armen Hareyan's picture

Small Cell Lung Cancer Trial

Poniard Pharmaceuticals announced that data from a Phase 2 trial of picoplatin in patients with small cell lung cancer will be presented in a poster session at the 43rd Annual Meeting of the American Society of Clinical Oncology.


Details are as follows:

-- Abstract #7722, Poster #EE3

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.